GSA CAPITAL PARTNERS LLP - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$221,000
-58.3%
10,610
-52.1%
0.02%
-59.0%
Q4 2018$530,000
+24.4%
22,137
+41.9%
0.06%
+154.2%
Q3 2018$426,000
-3.6%
15,600
-27.4%
0.02%
-17.2%
Q2 2017$442,000–21,500–0.03%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders